DiSilvestro et al. Conducted 8 weeks of research in 2007; by examining the increase in micronutrient intake of young adult women, we can improve the change in bone metabolism by exercise, thereby reducing the risk of later osteoporosis I will. The subjects were 24 female students aged 18 to 24 who were generally healthy and assigned to PG (placebo group, n = 12) or MG (micronutrient group, n = 12). Fasting blood and urine samples were taken before and after 8 weeks of study to determine the change: 25 - OH - vitamin D, parathyroid hormone (PTH), bone specific alkaline phosphatase (BAP) Urinary deoxypyridinoline (DPD) and helical peptide (AHP).
Movement: Exercise is an important part of the prevention and treatment program of osteoporosis. Exercise not only improves bone health but also improves muscle strength, coordination, balance, improving general health. Although exercise is beneficial for osteoporotic patients, you should not suddenly or excessively stress your bones. As an additional insurance against fractures, your doctor can recommend specific exercise to strengthen and support your back. Drugs: Drugs that can be used for the prevention and / or treatment of osteoporosis include bisphosphonates, estrogen agonists / antagonists (also known as selective estrogen receptor modulators or SERMS), and others. Calcitonin; parathyroid hormone; estrogen therapy; hormone therapy; and recently approved RANK ligand (RANKL) inhibitor
Estrogen agonists / antagonists: estrogen agonists / antagonists (also known as selective estrogen receptor modulators or SERMs) are approved for the prevention and treatment of osteoporosis in postmenopausal women. SERM is not an estrogen, but certain tissues have estrogenic effects and other tissues have estrogen blockade. Estrogen and hormonal therapy: The combination of estrogen, estrogen and progesterone (hormonal therapy) is approved for the treatment of moderate to severe hot flashes and vaginal dryness, which may be related to the prevention of postmenopausal osteoporosis and menopause . Estrogen without progesterone is recommended only for women who have undergone hysterectomy (surgical resection of the uterus). Estrogen increases the risk of endometrial cancer and progesterone reduces this risk.